Hysteroscope Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 6.60 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Hysteroscope Market Analysis
The hysteroscope market is expected to register a CAGR of 6.6% over the forecast period.
The COVID-19 pandemic was a challenge for healthcare providers across the world as due to the high infectivity of SARS-CoV-2, the resources were diverted for the care of COVID-19 patients which affected the healthcare services other than COVID-19 which also affected the hysteroscope market. During the COVID-19 pandemic, patients are being limited to some procedures, and those who delay the procedure could result in adverse clinical outcomes. To minimize this adverse outcome many hospital settings followed pre-procedure, intra-procedure, and post-procedure guidelines. For instance, in April 2020, Meditrina announced that it has designed a single-use resecting hysteroscope to reduce the risks and delays associated with ineffective reprocessing during the COVID-19 pandemic. This helped as an alternative for uterine surgical procedures to continue during the pandemic. As we already moved closer toward the return of elective procedures, the hysteroscope market is expected to grow in coming future.
A hysteroscope is used to assess the uterus for diagnosing abnormalities like heavy bleeding, severe cramping, frequent miscarriages, or problems related to conceiving and endometrial cancers. Hysteroscopes are used mainly for two purposes-operative and diagnostics.
Increasing incidence of edometrial cancer, have been the primary driving factor for the growth of this market. According to International Agency for Research on Cancer, 2020 the incidence rate of endometrial cancer is increasing rapidly and is estimated to increase by more than 50% worldwide by 2040. Also, growing demand for minimally invasive diagnosis and treatment equipment and technological advancements in the development of new hysteroscope technologies have also helped the market to grow. For instance, in March 2020, Meditrina Inc has introduced Aveta System a new see and treat resecting hysteroscope with HD vision and the smallest insertion diameter. With increasing incidence of endometrial cancer and new advancements in the hysteroscopes the market is expected to grow during the study period.
However, lack of trained professionals and risk of infection due to equipment have been restraining the growth of this market.
Hysteroscope Market Trends
This section covers the major market trends shaping the Hysteroscope Market according to our research experts:
Rigid Hysteroscope is Expected to Dominate the Market Over the Forecast Period
Rigid operative hysteroscopes are the diagnosis and surgery equipment that require assembly. Rigid Hysteroscopes are more durable than flexible hysteroscopes. The use of rigid hysteroscopes has increased recently as they allow both diagnosis and treatment. Rigid hysteroscopes are used in the treatment of various uterine abnormalities like removing polyps and fibroids and treating uterine cancer.
According to the National Health Service (NHS) 2022, around 2 in 3 women develop at least 1 fibroid at some point in life. They most often occur in women aged 30 to 50. It is more often seen in women of African-Caribbean origin. As the number of fibroid cases is significant, the demand for equipment for diagnosis and treatment will also increase. This factor is expected to increase the growth of rigid hysteroscopes.
Hence, owing to these factors, the rigid hysteroscope is expected to cover a large share of the hysteroscope market over the forecast period.
North America is Expected to Dominate the Market Over the Forecast Period
North America has developed countries with a well-structured healthcare system. As a result, the expenditure on research and development for equipment that is minimally invasive and more effective is also high. Also, the raise in uterine or endometrial cancers increases the demand for diagnosis using a hysteroscope.
According to the American Society of Clinical Oncology, Uterine Cancer: Statistics 2022, it is estimated that 65,950 people in the United States will be diagnosed with uterine, or endometrial, cancer in 2022. Also, as per the international journal of gynecology & obstetrics report titled "Cancer of the corpus uteri: 2021 update" published in October 2021, North America has the highest incidence of endometrial cancer, which is the most frequent cancer of the female genital tract, and the fifth most common site in women after breast, lung, colorectal, and non-basal skin cancer. Hence with the significant amount of Uterine or endometrial cancer cases, the demand for equipment for diagnosis and treatment for such illnesses will increase and helps in the growth of the market.
Furthermore, the new product approvals and launches help the segment to grow in the forecast period. For instance, in July 2021, Meditrina Inc launched their single-use Aveta Opal Hysteroscope and disposable Aveta Auto Resecting Device for removing soft endometrial tissue such as uterine polyps in an office setting, without the need for fluid management.
Hence, owing to these factors, North America is expected to cover a large share of the hysteroscope market.
Hysteroscope Industry Overview
The majority of the hysteroscope is being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. The major players include B. Braun SE, CooperSurgical Inc., Hologic Inc., Karl Storz SE & Co. KG, MedGyn Products, Inc., Medtronic, Olympus Corporation, Richard Wolf GmbH, Stryker, and XION.
Hysteroscope Market Leaders
-
Hologic Inc.
-
CooperSurgical Inc.
-
Medtronic
-
Olympus Corporation
-
Stryker
*Disclaimer: Major Players sorted in no particular order
Hysteroscope Market News
- In June 2022, UroViu Corp launched the new Hystero-V, a single-use semi-rigid hysteroscope compatible with UroViu's Always Ready endoscopy platform. The 12-Fr, semi-rigid, Hystero-V features a hydrophilic coating enabling gentle insertion and superior visualization for highly effective intra-uterine examinations.
- In September 2021, Hologic, Inc has launched its expanded Omni suite, a comprehensive gynecological surgical offering designed to optimize diagnostic and operative hysteroscopy, in Europe, Africa and the Middle East (EMEA).
Hysteroscope Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increase in Incidence of Uterine Diseases and Abnormalities
- 4.2.2 Growing Demand of Minimally Invasive Treatment
- 4.2.3 Technological Advancements Leading to Enhanced Applications
-
4.3 Market Restraints
- 4.3.1 Risk of Infection from Hysteroscopes
- 4.3.2 Lack of Trained Professionals
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
5.1 By Product
- 5.1.1 Rigid Hysteroscopes
- 5.1.2 Flexible Hysteroscopes
-
5.2 By Application
- 5.2.1 Polypectomy
- 5.2.2 Myomectomy
- 5.2.3 Endometrial Ablation
- 5.2.4 Others
-
5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Ambulatory Surgical Services
- 5.3.3 Others
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 B. Braun SE
- 6.1.2 CooperSurgical Inc.
- 6.1.3 Hologic Inc.
- 6.1.4 Karl Storz SE & Co. KG
- 6.1.5 MedGyn Products, Inc.
- 6.1.6 Medtronic
- 6.1.7 Olympus Corporation
- 6.1.8 Richard Wolf GmbH
- 6.1.9 Stryker
- 6.1.10 XION
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityHysteroscope Industry Segmentation
As per the scope of the report, a hysteroscope is a device that carries optical and light channels or fibers helping to diagnose and treat abnormalities in or around the uterine cavity. The hysteroscope market is segmented by product (rigid hysteroscopes and flexible hysteroscopes), application (polypectomy, myomectomy, endometrial ablation, and others), end user (hospitals, ambulatory surgical services, and others) and geography (North America, Europe, Asia Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product | Rigid Hysteroscopes | |
| Flexible Hysteroscopes | ||
| By Application | Polypectomy | |
| Myomectomy | ||
| Endometrial Ablation | ||
| Others | ||
| By End User | Hospitals | |
| Ambulatory Surgical Services | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Hysteroscope Market Research FAQs
What is the current Global Hysteroscope Market size?
The Global Hysteroscope Market is projected to register a CAGR of 6.60% during the forecast period (2024-2029)
Who are the key players in Global Hysteroscope Market?
Hologic Inc., CooperSurgical Inc., Medtronic, Olympus Corporation and Stryker are the major companies operating in the Global Hysteroscope Market.
Which is the fastest growing region in Global Hysteroscope Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Hysteroscope Market?
In 2024, the North America accounts for the largest market share in Global Hysteroscope Market.
What years does this Global Hysteroscope Market cover?
The report covers the Global Hysteroscope Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Hysteroscope Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Hysteroscope Industry Report
Statistics for the 2024 Global Hysteroscope market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Hysteroscope analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
